Enabling site success: Key insights to reducing burden and increasing access

Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards. Being an investigator and supporting clinical research, though, is not easy.

In addition to bringing new and innovative treatment options to patients, the business of conducting research can be an administrative burden and workload for sites and staff. Sites need partners dedicated to understanding a sites’ distinct challenges and driving solutions to ease burden, create a better experience for sites and patients, and expand access and representation in research.

Why attend?

Join us on Tuesday 12th November @ 10am ET / 4pm CET / 3pm GMT. Register now for this webinar, sponsored by Syneos Health, and let experts offer a closer look at clinical trial site success, offering insight into:

• Motivating Sites – Why Participate: what motivates a physician to become an investigator.
• Driving Success – Understanding Challenges: the challenges in being an investigator on a study.
• Making it Long-Term – Partnership Attributes: the attributes of a successful site partnership.
• Leveraging Technology – User Experience: the role data and technology play in clinical trials: bringing to life both the site and patient user experience.
• At the Centre – Patients: why the patient is at the centre of everything.

Following the discussion, attendees will have the opportunity to participate in a live Q&A session, further addressing specific challenges and gaining expert advice.

Don't miss this opportunity to learn from experts in the field how to enable clinical trial site success, reducing burden and increasing access.

About the speakers

Terttu Haring, MD
Terttu Haring, MD, is President, Clinical Sites & Patients, at Syneos Health. In her role, Dr Haring leads the global clinical operations organisation to drive exceptional delivery, quality, and data integrity for customers, while ensuring a positive experience for sponsors, sites, and patients.

Dr Haring has over 25 years of experience in the clinical development ecosystem, having seen clinical trials from several angles in a research site, large pharma, and CRO setting, including as an investigator and a research director; by managing local and regional teams in Netherlands, Europe & Africa; and through overseeing global trial operations and data management activities and pushing digital innovations to clinical operations.

Dr Haring received her MD from Maastricht University in the Netherlands and is based out of the Syneos Health office in Amsterdam.

Mark Scullion
Mark Scullion is Chief Executive Officer at Atlas Clinical Research. He has spent more than 15 years in the clinical research industry and brings a unique understanding of the site selection process and value needs of pharmaceutical sponsors.

Scullion was most recently the Global Head of Trial Monitoring for Novartis AG, and also previously held leadership roles at Syneos Health and IQVIA, where he developed novel approaches to clinical trial design and execution. At Novartis, Scullion led a group of clinical professionals delivering over 300 clinical studies in partnership with 14,000 investigative sites across the world.

Nicole Raleigh (moderator)
Nicole Raleigh is pharmaphorum’s Web Editor. Transitioning to the healthcare sector in the last few years, she is an experienced media and communications professional who has worked in print and digital for over 18 years.